Login / Signup

Comparing drug safety of hepatitis C therapies using post-market data.

Jing HuangXinyuan ZhangJiayi TongJingcheng DuRui DuanLiu YangJason H. MooreCui TaoYong Chen
Published in: BMC Medical Informatics Decis. Mak. (2019)
Keyphrases
  • market data
  • clinical trials
  • financial markets
  • market conditions
  • long term
  • special case
  • electronic markets
  • cost function
  • adverse drug reaction